House dust mite allergy vaccine injection - Alk-Abello

Drug Profile

House dust mite allergy vaccine injection - Alk-Abello

Alternative Names: Alutard; Alutard Der p; Alutard SQ; House dust mite SCIT - ALk-Abello; TO-204

Latest Information Update: 22 Dec 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator ALK-Abello
  • Developer ALK-Abello; Eddingpharm; Torii Pharmaceutical
  • Class Allergens; Allergy immunotherapies; Antiallergics
  • Mechanism of Action Immunomodulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Asthma
  • Registered Allergic rhinitis

Most Recent Events

  • 24 Apr 2014 House dust mite allergy injection licensed to Eddingpharm China
  • 23 Dec 2013 Preregistration for Asthma and Allergic rhinitis in Japan (SC)
  • 01 Jul 2012 Phase-III clinical trials in Asthma and Allergic rhinitis in Japan (SC)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top